Integrated Biosciences

Landmark study in cell introduces first-of-its-kind optogenetic screening platform for drug discovery

Researchers developed a novel optogenetic screening platform to control biological systems, unlocking new therapeutic opportunities. The platform enables precise and dynamic control of biological targets, resolving compound effects in real time.

SourceIntegrated Biosciences·JournalCell·TypeNews article·DateJul 14, 2025

Catalyzing drug discovery with explainable deep learning

A team of researchers identified a new structural class of antibiotics using an AI-powered platform built around explainable deep learning. The discovery shows potential to address antibiotic resistance, with the newly discovered antibiotics showing potent activity against multidrug-resistant pathogens.

SourceIntegrated Biosciences·JournalNature·TypeExperimental study·DateDec 20, 2023